Asthma Crisis: Experts Demand Subsidised Inhalers for Millions of Nigerians
Korede Abdullah 
LAGOS, Nigeria – The Nigerian Thoracic Society has called for urgent government intervention to subsidise asthma medications, warning that rising costs are pushing life-saving treatment beyond the reach of millions.
Marking the 2026 World Asthma Day, the society highlighted that more than 15 million Nigerians are affected by asthma, with many unable to access essential anti-inflammatory inhalers.
In a statement signed by President Prof. Musa Babashani and Secretary General Dr Oluwafemi Ojo, on Tuesday the group stressed that reliance on cheaper reliever inhalers is worsening health outcomes.
“Anti-inflammatory inhalers remain the cornerstone of treatment, yet they are increasingly unaffordable for the average Nigerian,” the statement said.
Babashani described access to asthma care as both a medical necessity and a human rights issue, urging inclusion of essential medications in national and state health insurance schemes.
The society also called on pharmaceutical companies to boost local production to stabilise supply and reduce costs, while encouraging clinicians to prioritise preventive treatment approaches.
About the Author
Oluwatobi Adu 
Edino Chubiyo Cornelius 
Oluwafunbi Bello 